Skip to main content
logo
Rafa Laboratories Ltd. (TLV:RAFA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,469.00
-4.00 (-0.27%)
At close: Aug 13, 2026

Rafa Laboratories Financials Overview

Millions ILS. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Revenue
459.86418.44420.08355.2
Revenue Growth
--0.39%18.27%-
Gross Profit
222.82198.11201.2158.29
Operating Income
134.77111.67114.0178.31
Net Income
123.16100.3499.4366.22
Earnings Per Share
0.040.030.030.02
EPS Growth
-0%54.55%-

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Pharmaceuticals
265.51262.81265.92275.01
Biodefense
194.35155.63154.1680.19
Total
459.86418.44420.08355.2

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Cash & Investments
32.1511.0612.82-
Total Debt
4.3416.86.08-
Net Cash (Debt)
27.81-5.746.73-
Net Cash Growth
----
Net Cash Per Share
0.01-0.000.00-

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
119.9798.7139.4341.2
Capital Expenditures
-8.58-3.55-3.72-8.04
Free Cash Flow
111.3895.15135.7133.16
Free Cash Flow Growth
--29.89%309.22%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Gross Margin
48.45%47.34%47.89%44.56%
Operating Margin
29.31%26.69%27.14%22.05%
Pretax Margin
29.36%26.48%26.24%21.32%
Profit Margin
26.78%23.98%23.67%18.64%
FCF Margin
24.22%22.74%32.30%9.34%